IAVI Receives US Funding for Ebola Vaccine Development
Research organization IAVI received U.S. funding for Ebola vaccine development, Reuters reported.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
IAVI Receives $36 Million in US Funding for Ebola Vaccine Development
IAVI said it was awarded $36 million under a US government contract worth up to $99 million to advance development of a single-dose vaccine candidate against the Bundibugyo strain of Ebola.